Relypsa's IPO

Relypsa raised a round of funding on November 15, 2013. Investors include Public.

Relypsa is a clinical-stage biopharmaceutical company leading the discovery and development of non-absorbed polymeric drugs for applications in cardiovascular and renal disease. Relypsa's lead product…

Articles about Relypsa's IPO: